Click image to enlarge
The R-PLEX platform offers both antibody sets and assays for a wide menu of biomarkers. The R-PLEX Human EGFR (soluble) Assay has the essential components to build an assay that measures EGFR in a single analyte format. For information on multiplexing EGFR (soluble) with other analytes, please see the
R-PLEX Assay Designer or the
R-PLEX Human EGFR (soluble) Antibody Set.
The Product Insert for R-PLEX Assays provides detailed instructions for building a singleplex assay. The datasheet for EGFR (soluble) provides information on the components (including calibrator stock concentration), recommended sample types and dilution factors, and representative data for analytical performance. These items and other helpful documents can be found in the "Documentation" tab below.
Related Key Termsepidermal growth factor receptor, ERBB1, HER1, NISBD2, PIG61, receptor tyrosine kinase, cancer, wound healing
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Oncology & Cancer
|
|
|
Analyte(s)
|
|
EGFR
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO SECTOR S 600MM
|
|
|
Plate Type
|
|
96-well
|
|
|
LLOD (Sensitivity)
|
|
0.58 pg/mL
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
1956
|
|
|
UniProt ID(s)
|
|
P00533
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Human EGFR Antibody Set
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
Human EGFR Calibrator
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 each
(1 plate)
|
|
|
|
|
2-8 °C
|
1 bottle
(50 mL)
|
|
|
|
|
2-8 °C
|
2 bottle
(150 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Handouts
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations
|
|
|
|
Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck.
|
|
|
|
Addiction to Elevated Insulin-like Growth Factor I Receptor and Initial Modulation of the AKT Pathway Define the Responsiveness of Rhabdomyosarcoma to the Targeting Antibody.
|
|
|
|
Multiplexing siRNAs to compress RNAi-based screen size in human cells.
|
|
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters